Northwire Canada EditionMonday, July 13, 2026
Sign inSubscribe
Northwire
⌕
BMM 3.80 +0.0% CGD 0.510 −10.5% OCG 0.275 −1.8% CAMB 0.990 −1.0% HMR 0.610 −1.6% GOFL 0.025 +0.0% SIG 1.02 −1.0% SGQ 0.300 +0.0% AMCO 0.220 −12.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.400 +0.0% LIB 0.790 −13.2% SMY 0.290 +23.4% SAG 1.02 +0.0% NTH 0.165 +0.0% BMM 3.80 +0.0% CGD 0.510 −10.5% OCG 0.275 −1.8% CAMB 0.990 −1.0% HMR 0.610 −1.6% GOFL 0.025 +0.0% SIG 1.02 −1.0% SGQ 0.300 +0.0% AMCO 0.220 −12.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.400 +0.0% LIB 0.790 −13.2% SMY 0.290 +23.4% SAG 1.02 +0.0% NTH 0.165 +0.0%
Earnings

Organigram to Report Fourth Quarter Fiscal 2025 Results on December 16, 2025

By The Northwire Desk — AI Analysis Dec 05, 2025 · 06:00 OGI · 2.29 ORGANIGRAM GLOBAL INC.
OGI · Price

Executive Summary

  • Organigram Global Inc. announced that it will release its fiscal Q4 2025 earnings (ended September 30, 2025) on Tuesday, December 16, 2025, prior to market open.
  • A conference call and webcast will be provided for investors and analysts at 8:00 a.m. ET, with registration details included.
  • The replay of the webcast will be available within 24 hours and archived for 90 days.

Key Details

  • Earnings Release Date: Tuesday, December 16, 2025 (pre‑market).
  • Reporting Period: Fourth quarter fiscal 2025, ended September 30, 2025.
  • Conference Call Time: 8:00 a.m. Eastern Time on the release date.
  • Registration Link for Call: https://registrations.events/direct/Q4I9676638
  • Webcast Access Link: https://events.q4inc.com/attendee/724034228
  • Replay Availability: Within 24 hours after the call at https://www.organigram.ca/investors; archived for 90 days.
  • Contact – Investor Relations: Max Schwartz, Director of IR ([email protected])
  • Contact – Media: Megan McCrae, SVP – Global Brands & Corporate Affairs ([email protected])

Notable Quotes

(No executive quotes were included in the release.)

Read the original news release →

More from ORGANIGRAM GLOBAL INC.

May 14, 2026 · 08:45

Organigram Left Watching as European Cannabis Boom Accelerates, Q2 Miss Deepens Share Slide

M&A / Property May 12, 2026 · 06:00

Organigram’s core Canadian business stumbles into the red just as its landmark Sanity Group deal closes, leaving investors to wonder if the European cure will be enough to offset domestic decay.

Earnings Apr 15, 2026 · 12:03

Organigram Executes Europe Pivot as BAT Deal Closes, Dilution Looms

Financings Mar 30, 2026 · 20:30

Organigram Clears Final Hurdle for Sanity Acquisition as Dilution and Cash Constraints Loom

Financings Mar 23, 2026 · 14:07

Organigram garners ISS support for Sanity transaction

M&A / Property Mar 23, 2026 · 06:00

Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH

M&A / Property